Blog

»  Posts By   June 2013 

New Jersey Diagnostic Lab Faces Fines and Criminal Penalties Over Illegal Payments to Physicians in Exchange for Referrals

This week, the owner of Biodiagnostic Laboratory Services LLC, a diagnostic lab in Parsippany, NJ, pleaded guilty in Federal Court to healthcare fraud, in connection with illegal payments or kickbacks made to doctors, in exchange for referrals to his lab facility. The plea, following a comprehensive investigation by Federal agencies, demonstrates the serious penalties and stepped up enforcement of Federal and State healthcare laws, including the Anti-Kickback Statute (particularly considering...

Walgreens Pay $80 Million Over Improper Procedures regarding Dispensing Controlled Substances: Avoid Similar Problems at Your Pharmacy

In a record settlement, Walgreens, the nation's largest pharmacy chain, agreed to pay $80 million to the Federal Government in connection with allegations that it committed an "unprecedented" number of violations of the record-keeping and dispensing requirements of the Controlled Substances Act. During the underlying investigation and prosecution, the DEA contended that Walgreens had negligently allowed controlled substances prescription painkillers (including oxycodone) to be improperly distributed to abusers and to...

Pharmacy Alert: State Boards of Pharmacy Requesting Information about Pre-Printed Prescription Pads, Physician In-Office Use

State Boards of Pharmacy (BOPs) have begun requesting very specific information from prescribing physicians about compounded medications. Pre-printed prescription pads and “office-use” are hot topics. Your pharmacy’s compliance with state regulation is critical to business success. The BOP likely lacks direct jurisdiction over physicians, whose licenses are typically governed by state Boards of Medical Examiners (BME). However, the mere receipt of an investigatory document from a governmental authority can be...